These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7986711)

  • 41. Concurrent chronic lymphocytic leukemia/small lymphocytic lymphoma and hairy cell leukemia: clinical, pathologic and molecular features.
    Obiorah IE; Francischetti IMB; Wang HW; Ahn IE; Wang W; Raffeld M; Kreitman RJ; Wiestner A; Calvo KR
    Leuk Lymphoma; 2020 Dec; 61(13):3177-3187. PubMed ID: 32755330
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 2-Chlorodeoxyadenosine (cladribine) in the treatment of elderly patients with B-cell chronic lymphocytic leukemia.
    Robak T; Błasińska-Morawiec M; Błoński JZ; Dmoszyńska A
    Leuk Lymphoma; 1999 Jun; 34(1-2):151-7. PubMed ID: 10350343
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Simultaneous diagnosis of hairy cell leukemia and chronic lymphocytic leukemia/small lymphocytic lymphoma: a frequent association?
    Giné E; Bosch F; Villamor N; Rozman M; Colomer D; López-Guillermo A; Campo E; Montserrat E
    Leukemia; 2002 Aug; 16(8):1454-9. PubMed ID: 12145685
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 2-Chlorodeoxyadenosine: treatment of hairy cell leukemia, chronic lymphocytic leukemia, and lymphocytic lymphoma.
    Piro LD
    Semin Hematol; 1993 Oct; 30(4 Suppl 6):28-30. PubMed ID: 7908756
    [No Abstract]   [Full Text] [Related]  

  • 45. Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias.
    Cheson BD; Vena DA; Barrett J; Freidlin B
    J Clin Oncol; 1999 Aug; 17(8):2454-60. PubMed ID: 10561309
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro cytotoxicity of 2-chlorodeoxyadenosine and chlorambucil in chronic lymphocytic leukemia.
    Begleiter A; Wang H; Verburg L; Lee K; Israels LG; Mowat MR; Johnston JB
    Leukemia; 1996 Dec; 10(12):1959-65. PubMed ID: 8946937
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Retreatment with 2-CdA of progressed HCL patients.
    Lauria F; Benfenati D; Raspadori D; Rondelli D; Ventura MA; Pileri S; Sabattini E; Poggi S; Benni M; Tura S
    Leuk Lymphoma; 1994; 14 Suppl 1():143-5. PubMed ID: 7820047
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of hairy cell leukaemia (HCL) with 2-chlorodeoxyadenosine (2-CdA): identification of parameters predictive of adverse effects.
    Legrand O; Vekhoff A; Marie JP; Zittoun R; Delmer A
    Br J Haematol; 1997 Oct; 99(1):165-7. PubMed ID: 9359518
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mycobacterium-avium-intracellulare complex infection following 2-chlorodeoxyadenosine therapy for hairy cell leukaemia.
    Broady R; Roberts S; Hawkins T
    Leuk Lymphoma; 2000 Feb; 36(5-6):639-42. PubMed ID: 10784410
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Successful treatment of patients with hairy cell leukemia (HCL) using a single cycle of 2-chloro-2'-deoxyadenosine (CdA).
    Jehn U; Gawaz M; Grunewald R; Hill W; Lorenz B; Stôtzer O
    Anticancer Res; 1993; 13(5C):1809-14. PubMed ID: 7903521
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cladribine decreases the level of angiogenic factors in patients with chronic lymphocytic leukemia.
    Gora-Tybor J; Blonski JZ; Robak T
    Neoplasma; 2002; 49(3):145-8. PubMed ID: 12097998
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hairy cell leukemia-variant treated with 2-chlorodeoxyadenosine--a report of three cases.
    Blasińska-Morawiec M; Robak T; Krykowski E; Hellmann A; Urbańska-Ryś H
    Leuk Lymphoma; 1997 Apr; 25(3-4):381-5. PubMed ID: 9168448
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [2-chlorodeoxyadenosine (2-CdA) cladribine therapy in hairy cell leukemia].
    Raanani P; Shpilberg O; Ben-Bassat I
    Harefuah; 1994 Jun; 126(11):673-6. PubMed ID: 7927005
    [No Abstract]   [Full Text] [Related]  

  • 54. 2-Chlorodeoxyadenosine (cladribine)-related eosinophilia in patients with lymphoproliferative diseases.
    Robak T; Błasińska-Morawiec M; Krykowski E; Hellmann A; Lewandowski K; Dmoszyńska A; Adamczyk-Cioch M; Kazimierczak M; Trepińska E; Dwilewicz-Trojaczek M; Kuratowska Z; Skotnicki AB; Nowak WS; Zdziarska B; Urasiński I
    Eur J Haematol; 1997 Oct; 59(4):216-20. PubMed ID: 9338619
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 2-Chlorodeoxyadenosine alone and in combination with cyclophosphamide and mitoxantrone induce apoptosis in B chronic lymphocytic leukemia cells in vivo.
    Rogalińska M; Błoński JZ; Hanausek M; Walaszek Z; Robak T; Kiliańska ZM
    Cancer Detect Prev; 2004; 28(6):433-42. PubMed ID: 15582267
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chemotherapy of chronic haematological malignancies.
    Ho AD
    Baillieres Clin Haematol; 1991 Jan; 4(1):197-221. PubMed ID: 2039859
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immune thrombocytopenia in patients with chronic lymphocytic leukemia treated with cladribine-based regiments or chlorambucil--follow-up of PALG-CLL randomized trials.
    Blonski JZ; Robak T; Chojnowski K; Gora-Tybor J; Warzocha K; Ceglarek B; Seferynska I; Calbecka M; Kostyra A; Stella-Holowiecka B; Kloczko J; Dmoszynska A; Kowal M; Lewandowski K; Dwilewicz-Trojaczek J; Wiater E; Kuliczkowski K; Potoczek S; Hellmann A; Mital A; Skotnicki A; Nowak W; Sulek K; Zawilska K; Trelinski J
    Eur J Haematol; 2013 Jul; 91(1):1-9. PubMed ID: 23521128
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular evaluation of clonal remission in hairy cell leukemia patients treated with 2-chlorodeoxyadenosine.
    di Celle PF; Reato G; Raspadori D; Carbone A; Rondelli D; Lauria F; Foà R
    Leuk Lymphoma; 1994; 14 Suppl 1():139-42. PubMed ID: 7820046
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Scripps Clinic experience with 2-chlorodeoxyadenosine in the treatment of hairy cell leukemia.
    Piro LD; Ellison DJ; Saven A
    Leuk Lymphoma; 1994; 14 Suppl 1():121-5. PubMed ID: 7820043
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Autoimmune haemolysis in patients with B-CLL treated with chlorodeoxyadenosine (CDA).
    Chasty RC; Myint H; Oscier DG; Orchard JA; Bussutil DP; Hamon MD; Prentice AG; Copplestone JA
    Leuk Lymphoma; 1998 Apr; 29(3-4):391-8. PubMed ID: 9684936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.